| Lactose (India) Ltd | 126 Cr. | 99.8 | 231/84.3 | 27.8 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.54 Cr. | 1.85 | 4.29/1.76 | | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 4,816 Cr. | 443 | 479/192 | 99.7 | 24.3 | 0.15 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 36.3 Cr. | 49.0 | 88.6/37.2 | | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 50.6 Cr. | 34.6 | 35.0/17.0 | 120 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 62.4 Cr. | 82.9 | 119/69.7 | 16.9 | 60.3 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 56,755 Cr. | 2,011 | 2,286/1,275 | 22.6 | 340 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 310 Cr. | 12.7 | 19.0/10.8 | 18.6 | 8.79 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 6.90 Cr. | 11.7 | 18.0/9.25 | 86.2 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 805 Cr. | 1,705 | 1,999/635 | 27.8 | 334 | 0.04 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 92.5 Cr. | 18.5 | 32.0/17.0 | 25.3 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 1,042 Cr. | 354 | 449/219 | 9.31 | 133 | 0.71 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 3.52 Cr. | 16.8 | 39.0/16.8 | | 19.2 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 9.21 Cr. | 3.70 | 8.28/2.11 | 5.24 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 445 Cr. | 458 | 499/211 | 67.2 | 74.7 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,129 Cr. | 952 | 1,565/951 | 37.4 | 406 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 59.3 Cr. | 0.29 | 1.12/0.24 | 3.90 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 43.6 Cr. | 16.6 | 26.3/11.4 | 21.3 | 24.5 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 9.80 Cr. | 9.70 | 17.2/9.00 | | 19.0 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 161 Cr. | 452 | 859/431 | 9.14 | 596 | 0.33 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 85.0 Cr. | 85.0 | 92.5/26.1 | 160 | 34.4 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 14,024 Cr. | 1,340 | 2,452/1,315 | 43.6 | 174 | 0.80 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 20.7 Cr. | 45.2 | 88.7/36.1 | 44.9 | 21.6 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 13.0 Cr. | 5.18 | 7.66/2.97 | | 13.0 | 0.00 % | 10.6 % | 30.3 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 16.0 Cr. | 107 | 152/63.0 | | 9.60 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 54.0 Cr. | 98.7 | 114/9.41 | 37.2 | 3.60 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 34.0 Cr. | 45.0 | 80.0/33.0 | 54.8 | 40.3 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 6.30 Cr. | 21.0 | 25.4/15.5 | | 12.3 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 9,168 Cr. | 529 | 1,028/512 | 26.0 | 72.4 | 0.23 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 88.7 Cr. | 20.6 | 35.9/18.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 11.7 Cr. | 23.0 | 43.7/17.4 | 50.7 | 18.6 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 90,489 Cr. | 2,193 | 2,998/2,090 | 54.3 | 376 | 0.05 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 253 Cr. | 440 | 524/241 | 26.0 | 123 | 1.02 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 49.1 Cr. | 34.2 | 56.6/26.7 | 76.8 | 18.4 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 69,984 Cr. | 1,206 | 1,365/994 | 20.4 | 603 | 0.33 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 163 Cr. | 262 | 303/159 | 155 | 69.9 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 801 Cr. | 80.5 | 122/74.0 | 20.7 | 32.6 | 1.86 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 37.6 Cr. | 28.8 | 46.0/21.0 | | 50.0 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 13,529 Cr. | 1,653 | 1,902/919 | 60.4 | 173 | 0.09 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 4.23 Cr. | 0.64 | 1.33/0.51 | 106 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 236 Cr. | 30.8 | 60.0/26.0 | 15.1 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 5.14 Cr. | 8.78 | 22.2/7.60 | | 2.75 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 133 Cr. | 5.64 | 6.57/2.82 | 309 | 1.34 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 61,205 Cr. | 28,905 | 37,000/25,260 | 40.6 | 1,888 | 1.64 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 6,725 Cr. | 742 | 972/557 | 28.0 | 226 | 0.67 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 201 Cr. | 70.8 | 100/31.3 | 56.2 | 52.5 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 5,097 Cr. | 1,537 | 1,740/752 | | 103 | 0.07 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 23,307 Cr. | 1,434 | 1,870/1,110 | 425 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 823 Cr. | 235 | 330/154 | 19.1 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 171 Cr. | 20.6 | 29.4/20.5 | | 5.79 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 1,065 Cr. | 788 | 849/270 | 16.8 | 445 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 3,156 Cr. | 445 | 791/432 | 21.7 | 346 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,468 Cr. | 1,038 | 1,443/991 | 20.8 | 768 | 0.96 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,29,165 Cr. | 3,817 | 3,882/2,886 | 59.6 | 250 | 0.84 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 937 Cr. | 102 | 284/98.0 | | 41.3 | 0.49 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,355 Cr. | 14.4 | 23.5/14.1 | 21.6 | 4.00 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 20,575 Cr. | 537 | 1,328/518 | 59.9 | 99.0 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 3,775 Cr. | 166 | 303/102 | | 12.4 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,12,447 Cr. | 1,720 | 1,910/1,547 | 35.7 | 324 | 0.93 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,504 Cr. | 560 | 734/441 | 391 | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 2,869 Cr. | 306 | 335/175 | 35.4 | 81.2 | 0.13 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 6,250 Cr. | 321 | 502/265 | 40.4 | 125 | 0.16 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 5,432 Cr. | 214 | 260/111 | 126 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 9,434 Cr. | 4,095 | 6,718/4,050 | 25.6 | 340 | 2.86 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 3,915 Cr. | 2,363 | 2,725/1,772 | 35.1 | 335 | 0.85 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 9,376 Cr. | 5,644 | 6,739/4,904 | 30.6 | 373 | 2.21 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 172 Cr. | 48.7 | 85.0/42.0 | | 14.7 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 23,134 Cr. | 5,052 | 5,993/3,701 | 32.7 | 841 | 0.69 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 128 Cr. | 104 | 220/81.0 | 13.2 | 86.5 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,498 Cr. | 407 | 582/281 | | 135 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 3,877 Cr. | 763 | 1,998/604 | 74.2 | 251 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 19,203 Cr. | 14,978 | 19,748/10,060 | 98.1 | 1,263 | 0.08 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 449 Cr. | 20.1 | 41.4/13.0 | | 32.0 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 16,272 Cr. | 908 | 1,420/660 | 10.6 | 483 | 0.66 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 2,262 Cr. | 41.3 | 80.7/38.4 | 30.0 | 21.8 | 0.48 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 8,117 Cr. | 179 | 308/162 | 23.1 | 59.3 | 0.45 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 37.6 Cr. | 23.8 | 130/23.1 | | 80.5 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 267 Cr. | 74.8 | 167/72.2 | 131 | 28.3 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 96,403 Cr. | 2,112 | 2,403/1,774 | 22.3 | 430 | 0.57 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 964 Cr. | 480 | 872/464 | 12.0 | 357 | 0.37 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 58,572 Cr. | 1,085 | 1,093/501 | 85.8 | 91.1 | 0.11 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 1,143 Cr. | 1,101 | 1,235/596 | 23.3 | 281 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 153 Cr. | 70.6 | 114/63.6 | | 73.2 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 715 Cr. | 149 | 220/123 | 40.6 | 104 | 2.02 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 609 Cr. | 344 | 500/265 | 22.1 | 152 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 17,108 Cr. | 1,075 | 1,250/802 | 34.4 | 414 | 0.47 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 28,506 Cr. | 1,819 | 1,918/1,303 | 39.7 | 243 | 0.85 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,307 Cr. | 197 | 302/192 | 29.9 | 38.0 | 1.27 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 36,553 Cr. | 1,440 | 1,758/1,168 | 36.9 | 293 | 0.28 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,391 Cr. | 81.4 | 127/57.5 | 20.6 | 59.7 | 0.98 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 34.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 747 Cr. | 91.5 | 124/67.2 | 25.2 | 160 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 2,087 Cr. | 226 | 350/190 | | 106 | 0.09 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,878 Cr. | 234 | 457/217 | 285 | 96.9 | 0.60 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,357 Cr. | 1,587 | 2,496/1,243 | 31.0 | 397 | 0.44 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 3,345 Cr. | 334 | 498/285 | 61.6 | 62.7 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 14,981 Cr. | 617 | 627/412 | 29.3 | 164 | 0.24 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 56,755 Cr. | 2,011 | 2,286/1,275 | 22.6 | 340 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 41,784 Cr. | 2,464 | 3,516/1,921 | 43.8 | 101 | 1.70 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 27,252 Cr. | 1,654 | 2,131/1,200 | 23.6 | 610 | 1.09 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 6,609 Cr. | 407 | 528/359 | 29.3 | 149 | 1.23 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 20,791 Cr. | 1,526 | 1,910/1,097 | 50.0 | 227 | 0.48 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,05,894 Cr. | 1,269 | 1,406/1,020 | 18.4 | 432 | 0.63 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 3,901 Cr. | 249 | 322/178 | 26.1 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,21,646 Cr. | 1,506 | 1,673/1,310 | 22.4 | 408 | 0.86 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 14,575 Cr. | 1,916 | 2,641/1,551 | 24.8 | 416 | 0.31 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 254 Cr. | 86.3 | 203/84.5 | 18.2 | 39.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,765 Cr. | 167 | 191/105 | 16.1 | 107 | 0.30 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 55.2 Cr. | 33.8 | 63.1/32.5 | 19.4 | 13.1 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 52,910 Cr. | 395 | 425/291 | 112 | 200 | 0.13 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,569 Cr. | 1,554 | 2,046/1,430 | 34.7 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 113 Cr. | 71.9 | 132/70.0 | 16.6 | 49.2 | 1.67 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 387 Cr. | 164 | 205/67.8 | 36.6 | 38.6 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 22,210 Cr. | 8,879 | 10,691/6,301 | 96.1 | 320 | 0.36 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,979 Cr. | 684 | 843/544 | 34.9 | 118 | 0.67 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 162 Cr. | 76.4 | 137/73.6 | 8.59 | 92.0 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 66,205 Cr. | 5,535 | 5,868/4,492 | 28.2 | 1,116 | 0.81 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 16,750 Cr. | 852 | 1,124/725 | 26.4 | 271 | 1.29 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 426 Cr. | 745 | 1,412/736 | | 690 | 0.67 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 33,403 Cr. | 2,682 | 3,116/2,022 | 34.3 | 345 | 1.04 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,314 Cr. | 296 | 367/258 | 22.5 | 133 | 1.76 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 3,787 Cr. | 417 | 575/312 | 19.9 | 147 | 0.24 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 20,100.18 Cr | 1,149.90 | | 52.73 | 202.18 | 0.35% | 16.29% | 15.20% | 6.10 |